Finch Therapeutics Group, Inc. (NASDAQ:FNCH – Get Free Report) saw a significant increase in short interest during the month of August. As of August 15th, there was short interest totalling 21,400 shares, an increase of 57.4% from the July 31st total of 13,600 shares. Currently, 3.8% of the shares of the company are short sold. […]
Shares of Finch Therapeutics Group, Inc. (NASDAQ:FNCH – Get Rating) are set to reverse split before the market opens on Monday, June 12th. The 1-30 reverse split was announced on Monday, June 12th. The number of shares owned by shareholders will be adjusted after the closing bell on Monday, June 12th. Finch Therapeutics Group Stock […]